Enter your login e-mail to the account
Search
- Treatment with the monoclonal antibody alemtuzumab: effect on the manifestation of thyroid disorders
Prof. MUDr. Petr Vlček, CSc., RNDr. Dana Nováková
(4/2017, From the boundary of neurology ) - Immunomodulatory properties of intravenous immunoglobulin
MUDr. Jiří Piťha
(5/2014, Review articles )
- Intravenous immunoglobulins and their immunomodulatory effect in pediatrics
prof. MUDr. László Kovács, DrSc., MPH, doc. MUDr. Pavol Sýkora, CSc., doc. MUDr. Peter Čižnár, CSc.
(2/2012, Review articles ) - When thrombocytopenia is not immune thrombocytopenic purpura
MUDr. Hana Flögelová, doc. MUDr. Dagmar Pospíšilová, Ph.D., MUDr. Lucie Sulovská, MUDr. Ivana Stejskalová, RNDr. Ingrid Hrachovinová
(6/2013, Case reports )
- First administration of caplacizumab in first-line treatment for acquired acute thrombotic thrombocytopenic purpura – casuistry
MUDr. Renáta Pizurová, MUDr. Pavol Hollý, PhD., MUDr. Tomáš Šimurda, PhD., MUDr. Juraj Chudej, PhD., MBA, doc. MUDr. Juraj Sokol., PhD., MBA, MUDr. Kristína Mária Beláková, Prof. MUDr. Ján Staško, PhD., MUDr. Ján Hudeček, PhD., Ing. Ingrid Škorňová, PhD., MUDr. Alena Ježíková
(S1/2024, Case reports ) - GROWTH FACTORS IN ONCOLOGY (part 2)
MUDr. Adriana Kafková, prof. MUDr. Elena Tóthová, CSc.
(6/2007, Review articles )
- Intravenous immunoglobulin in therapy of pemphigus vulgaris
prof. MUDr. Danka Švecová, PhD.
(4/2015, Review articles )